The 2021 Global R&D Funding Forecast Sponsor
AdisInsight is your complete pharma insights platform.
A trusted resource for over 25 years and now backed by Springer Nature one of the largest, most respected scientific and medical publishers. Our experts curate information from a wide range of sources to create trusted, relevant, and up-to-date actionable intelligence about drug development programs, clinical trials, patents and regional exclusivities, adverse events, and commercial deals.
Whether you’re looking for the complete picture or want to ensure you’re not missing the critical details, you’ll find your insights in our quick and easily searchable platform.
Interactive Global R&D Spending Over Time - as % of GDP
As noted, the global R&D forecast changed dramatically during 2020, as the most dire economic predictions made early in the year failed to materialize. At least part of this change was the result of proven and implemented vaccines in numerous countries near the end of the 2020.
Our global R&D forecasts are strongly based on the individual economies of countries. This influence obviously varies, especially in the presence of a pandemic. The country GERD forecasts also are based on historic economic distributions for R&D. For example, China has for more than 20 years consistently invested heavily in its R&D. As a result, though its economic growth was hampered because of the pandemic (as was the case in all other countries), its historic investment of roughly 10% annual increases resulted in a rise in R&D for 2020. Almost all other countries (including the U.S.) saw their 2020 R&D investments decline from what they invested in 2019.